SCHEMBL16076237

SCHEMBL16076237

CCCCn1c(=O)c2c(nc(SC(C)C)n2Cc2ccc(Cl)cc2)n(C)c1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.77
▸ TSHR P16473 7/20 0.77
▸ MAPT P10636 4/20 0.77
▸ NPSR1 Q6W5P4 3/20 0.77
▸ MAPK1 P28482 2/20 0.77
▸ MEN1 O00255 4/20 0.63
▸ KMT2A Q03164 4/20 0.63
▸ HPGD P15428 3/20 0.63
▸ TP53 P04637 2/20 0.56
▸ XBP1 P17861 1/20 0.56
▸ HTT P42858 1/20 0.53
▸ HSD17B10 Q99714 2/20 0.52
▸ GAA P10253 1/20 0.52
▸ ATM Q13315 2/20 0.52
▸ USP2 O75604 1/20 0.52
▸ CXCL8 P10145 1/20 0.51
▸ NOD2 Q9HC29 1/20 0.51
▸ NOD1 Q9Y239 1/20 0.51
▸ LMNA P02545 3/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19505591 0.91 ALDH1A1 (0.76) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL16076233 0.89 TSHR (0.63) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL16076235 0.88 TSHR (0.78) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL21499679 0.86 ALDH1A1 (0.68) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL16076164 0.82 MAPT (0.61) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL16076179 0.82 MAPT (0.61) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL16076165 0.82 TSHR (0.68) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL18834230 0.82 TSHR (0.70) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL18834862 0.81 BRAF (0.63) ALDH1A1TSHRMAPTNPSR1MAPK1
SCHEMBL16079036 0.80 ALDH1A1 (0.60) ALDH1A1TSHRMAPTNPSR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969736-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, INC. (US) 2018-05-15 — — US disclosed
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-10-26 — — US disclosed
US-20160237089-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, INC. 2016-08-18 — — US disclosed
US-20140275071-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, INC. (US) 2014-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885MAPT 2951/4885
US-20140275071-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885MAPT 2951/4885
US-20160237089-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885MAPT 2951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback